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We examine the potential for a broad range of small animal cells, including rodent, mink, and avian cells, from multiple
tissues to support postintegration steps of HIV-1 replication. These cells were engineered so as to support a stable
expression of human cyclin T1 and were further transduced with HIV-1 gag and pol genes. Viral gene expression was
activated by the presence of human cyclin T1, but, with the exception of mink cells, was not at the level seen in human cells.
Furthermore, there were considerable defects in p24 CA release, in particular in the case of rodent cells. Fractionation of Gag
proteins by sucrose floatation revealed that the Gag in human cells trafficked to membrane fractions and was processed to
p24 CA and p17 MA efficiently. Confocal imaging demonstrated that Gag was localized in a punctate pattern at the plasma
membrane as well as intracellular membrane trans-Golgi cisternae in these cells. In contrast, the majority of Gag in rodent
cells was largely present in cytosolic complexes and remained unprocessed. Labeling with [9,10(n)-3H]myristic acid showed
a similar degree of N-myristoylated Pr55gag in rodent and human cells, indicating that while N-myristoylation of Gag was
essential for membrane binding, it was not sufficient to confer membrane targeting specificity. Remarkably, despite the
reduced level of intracellular Gag processing, mink Mv.1.Lu cells did not appear to differ significantly from human cells in
support of virion assembly and release. Analysis of reciprocal heterokaryons suggested that the cellular factor(s) required
for efficient assembly and release of infectious virions is lacking in murine cells but appears to be functionally present in mink
as well as human cells. Our findings confirm and extend previous reports of multiple blocks to HIV replication in nonhumanas novel model systems for studying HIV-1 infection and d
INTRODUCTION
Human immunodeficiency virus type 1 (HIV-1) is a
lymphocytopathic virus that causes an immunodefi-
ciency syndrome characterized by severe deficiency of
CD4 T cell functions and significant CD4 T cell decline
in infected individuals. Studies in vivo for understanding
the mechanism of HIV-1 pathogenesis and for large-
scale evaluation of the efficacy of potential anti-HIV-1
therapies or vaccines have been hampered since hu-
mans and certain nonhuman primates, such as chimpan-
zees, appear to be the sole hosts for HIV-1. With
well-characterized immune systems and experimental
utilities, including low cost and ease of genetic manipu-
lations, transgenic mice and rats whose CD4 T lympho-
cytes could support HIV replication held promise as an
ideal in vivo small animal model. However, it became
clear that there are multiple blocks to HIV replication in
these rodent cells. Mouse primary lymphocytes engi-
neered to express receptors for HIV-1 infection, human
CD4 (hu-CD4), and human CCR5 (hu-CCR5) or human
CXCR4 (hu-CXCR4) were found to be susceptible to HIV-1
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infection, with preintegration forms of provirus detected
following infection (Browning et al., 1997; Sawada et al.,
1998). This indicates that HIV-1 virions can bind to and
fuse with mouse lymphoid cells expressing hu-CD4 and
coreceptor, with subsequent reverse transcription of the
genomic viral DNA. However, these mouse lymphoid
cells exhibited few or no signs of productive infection
(Browning et al., 1997; Sawada et al., 1998), which means
that the replicative ability of HIV-1 could still be nega-
tively controlled by the intracellular milieu of murine
cells. Recently, transgenic rats that express hu-CD4 and
hu-CCR5 on lymphocytes, macrophages, and microglia
were shown to support HIV-1 replication at levels higher
than those of comparable transgenic mouse models,
raising the possibility that these animal species provide
a useful small animal model of HIV-1 infection (Keppler et
al., 2002).
Intracellular blocks of HIV-1 replication in mouse cells
had been well documented; transfection of HIV proviral
DNA into mouse cells or introduction into transgenic
mice was followed by gene expression, albeit much less
efficient than that in permissive human cells (Levy et al.,
1986; Leonard et al., 1988). This intracellular restriction
could be partially overcomed by the introduction of hu-cells that are most profound in murine cells. They also raise
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man cyclin T1 (Wei et al., 1998), species-specific cellular
host factors that are required for the function of HIV-1the po
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regulatory protein Tat. However, HIV-1 does not establish
productive infection in murine cells genetically engi-
neered with these human cofactors (Garber et al., 1998;
Bieniasz and Cullen, 2000; Mariani et al., 2000). Recently,
additional blocks to the late phase of viral replication,
including Gag polyprotein processing, virion assembly,
and release, that result in the failure of the virus to
spread have been reported (Bieniasz and Cullen, 2000;
Mariani et al., 2000, 2001).
In this study, we further examined this late phase
intracellular regulation of HIV-1 replication and deter-
mined if the assembly defect is specific for rodent spe-
cies. A broad range of cell types from different species
stably expressing HIV-1 gag/pol as well as functional
cyclin T1 genes were generated and examined for their
abilities to support the postintegration phase of HIV-1
replication. Biochemical membrane fractionation studies
and confocal microscopy using organelle-specific green
fluorescence protein (GFP) vectors were used to track
processing and localization of Gag proteins within the
various cell types. Heterokaryons between assembly-
resistant and permissive cells were tested for their po-
tential to assemble and release virus in order to better
understand the basis for the block in productive HIV
replication. We found that among cells of small animal
cells, the defect in Gag assembly/release is most prom-
inent in the rodent species, although there are intraspe-
cies variations. This defect in the infectious HIV-1 parti-
cle production of rodent cells is due to the lack of one or
more species-specific cellular cofactors that facilitate
specific targeting of Gag polyprotein to the plasma mem-
brane prior to viral assembly and budding. Significantly,
the finding that mink cells support HIV replication to a
level that is comparable to that seen in human cells
suggests that further evaluation of this small animal as a
model for studies of HIV infection is warranted.
RESULTS
Differential synthesis of HIV-1 Gag/Pol in stable small
animal cell lines expressing hu-cyclin T1
To further examine the basis for the block to HIV
assembly and release in rodent cells, and to extend our
knowledge to cells from other small animals, avian, mink,
and rodent cell lines stably expressing the hu-cyclin T1
and the HIV-1 gag, pol genes were established. For this
purpose, small animal cells, with or without the hu-cyclin
T1 gene, were infected with the replication-incompetent,
VSV-G pseudotyped HIV-puro virus and selected for pu-
romycin resistance. The genome of HIV-puro contains
full-length HIV-1NL43 proviral DNA with a frameshift in the
env gene and an SV40 promoter regulating a puromycin-
resistant gene. Intracellular HIV-1 Gag expression in the
various cell lines was examined using anti-p24 CA MAb
VAK4 followed by indirect immunofluorescent staining
and flow cytometry. VAK4 recognized the carboxyl-termi-
nal portion of Gag p24 CA and reacted with precursor
Pr55gag and the intermediate precursor Pr40gag as well as
fully processed p24 CA (Koito et al., 1988). Thus, Gag
protein expression including unprocessed precursors
can be detected and quantitated based on fluorescence
intensities.
Consistent with previous reports of the restoration of
transactivation activity in hamster CHO and mouse
NIH3T3 cells by hu-cyclin T1 expression (Bieniasz et al.,
1998; Garber et al., 1998; Kwak et al., 1999), an increase
in Gag fluorescence, indicative of enhancement of pro-
viral expression, was seen in all the rodent cells we
examined (Fig. 1A). Gag expression was more pro-
nounced in avian and mink cells but was robust in mink
cells. The level of Gag expression in Mv.1.Lu cells was
comparable to that in human PM1 and HeLa cells and
was independent of hu-cyclin T1 expression. These find-
ings indicate that mink cells, unlike those from rodent
and avian sources, carry cellular host factors required to
support the functions of HIV-1 Tat.
Defects in virus-like particle (VLP) release in rodent
cell lines stably expressing HIV-1 Gag/Pol and
hu-cyclin T1
To assess the efficiency of virus assembly and release
in various cell lines, virus-like particle (VLP) production in
culture supernatant was determined using a p24-specific
ELISA assay. We found that human PM1, HeLa, and 293T
cells carrying HIV-puro released considerable amounts
of VLP into the culture supernatant, yielding p24 CA
concentrations of approximately 1000 ng/ml (Fig. 1B).
These cell lines stably secrete p24 CA, albeit with a
slight reduction in expression levels after several months
(data not shown). In contrast, HIV-1 Gag proteins were
mainly cell-associated in rodent cells, even in the pres-
ence of hu-cyclin T1. Only small amounts of VLP, 4- to
5-log fold lower than the levels of p24 seen for human
cells, were detected in culture supernatants of the
mouse T cell line EL4, the muscle cell line NOR10, and
fibroblast NIH3T3 cells (Figs. 1A and 1B). A similar pat-
tern was observed in the murine T cell line BW5147,
macrophage cell line RAW264 carrying HIV-1 gag, pol,
and hu-cyclin T1 (data not shown). Intraspecies varia-
tions were evident. The murine muscle cell line NOR10
and rat myelomonocytic WRT7 cells showed approxi-
mately 5- to 10-fold higher levels of p24 release than
other murine cells and the hamster cell line CHO showed
significantly higher levels of p24 secretion, such being
consistent with a report that this cell line could support at
least some levels of HIV-1 replication (Bienasz and
Cullen, 2000).
Nonmammalian avian cells, such as a chicken embri-
onic fibroblasts CEF and quail QT6 cells, produced con-
siderably higher levels of VLP than the murine cells,
albeit over 100-fold below those of the human cell lines.
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In the mink Mv.1.Lu cell line, the level of VLP release was
comparable to that found in human cells. Thus, mink
cells appear to support virus assembly and egress to a
degree comparable to that of human cells.
Membrane targeting and proteolytic processing of
HIV-1 pr55gag are defective in rodent cells
To further examine the basis for the block in late phase
HIV-1 replication in murine cells, we first looked at the
intracellular localization of Gag polyprotein as well as the
expression and processing of Gag using membrane floa-
tation assays (Spearman et al., 1997). We found that Gag
in human PM1 and HeLa cells tended to float up through
the sucrose cushion to the 10 to 65% sucrose interface,
and this membrane-bound Gag was efficiently pro-
cessed into p24 CA and p17 MA (Fig. 2). Differences in
the targeting to membrane fractions as well as the level
of intracellular processing of the Gag precursor were
evident between human and murine cells. Gag was
found predominantly in the bottom part of the gradient in
an unprocessed form in rodent WRT7 and NIH3T3 cells;
hence there was inefficient processing and targeting to
the cell membrane. Profound defects in the degree to
which p55gag was processed were also noted in the
murine lymphoid EL4 cell line (data not shown). An in-
termediate phenotype in membrane targeting and pro-
teolytic processing of Pr55gag were observed in avian
QT6 cells. In mink Mv.1.Lu cells, Gag trafficked to the
membrane fractions as efficiently as seen in human cell
lines (Fig. 2), yet the majority of polyprotein remained
unprocessed. Thus, the level of intracellular p55gag pro-
cessing does not correlate with membrane targeting
efficiency. Since the level of p24 CA release in the mink
cell line was comparable to that seen in human PM1 and
FIG. 1. Human cyclin T1 restores the intracellular HIV-1 Gag expression but not virion assembly in the murine cells. (A) Human or nonhuman cell
lines with (in gray shaded area) or without (solid tracing) transduced hu-cyclin T1 were infected with HIV-puro (VSV-G). After selection in the presence
of puromycin, intracellular expression of HIV-1 Gag proteins (p24 CA, Pr41Gag, and Pr55Gag) were detected by MAb against p24 CA subsequent to
fixation and permeabilization. The dotted line indicates the staining of uninfected parental cells. (B) p24 levels in the culture supernatants. Culture
supernatants of human or nonhuman cell lines with transduced hu-cyclin T1 expressing HIV-1 gag and pol genes were harvested and analyzed for
p24 antigen content.
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HeLa cells (Fig. 1B), the efficacy of viral release from the
cell does not correlate with the extent of intracellular
processing of p55gag.
Gag polyproteins localize primarily in large cytosolic
complexes in murine cells
To determine intracellular localization of Gag polypro-
teins in the various cell types, plasmids encoding Ae-
quorea victoria green fluorescent protein (GFP), variant
EYFP fused to plasma membrane Golgi or ER-specific
sequences, were used in transfection experiments. La-
ser scanning confocal microscopy, coupled with immu-
nochemistry, was used to visualize the presence of Gag
in each of the organelles. As expected, significant
amounts of intracellular Gag polyproteins were ex-
pressed in human HeLa cells, some of which colocalized
in a punctate pattern with the N-terminal neuromodulin-
tagged EYFP at the plasma membrane (Fig. 3). This
finding is consistent with previous observations made
using cytological as well as biochemical methods show-
ing that Gag polyprotein predominantly localizes in dis-
crete regions or subdomains of the plasma membrane of
human cells (Gottlinger et al., 1989; Bryant and Ratner,
1990; Hermida-Matsumoto and Resh, 2000; Lindwasser
and Resh, 2001). Gag polyprotein expressed in human
cells also colocalized with EYFP-Golgi in the trans cis-
ternae of the Golgi regions (Fig. 3), which means that
HIV-1 Gag also targeted some intracellular membranes
in human cells and not exclusively the plasma mem-
brane. A similar overlay with EYFP-Golgi was observed
in the case of human 293T cells (data not shown).
In contrast, analysis of Gag in murine NIH 3T3 cells
revealed diffuse cytoplasmic staining with no clear local-
ization to the plasma membrane (Fig. 3B), findings con-
sistent with the failure of Gag to target appropriately in
mouse cells (Mariani et al., 2000, 2001; Bieniasz and
Cullen, 2000). No costaining of Gag with ER was ob-
served in human HeLa or murine NIH 3T3 cells.
HIV-1 Gag polyprotein in human and murine cells is
similarly myristoylated
Mutation in the N-terminus of MA that blocks mem-
brane targeting had been reported to result in viruses
that failed to assemble or process efficiently in human
cells (Freed et al., 1994), a phenotype which is similar to
that of wild-type HIV-1 Gag in murine cells (Bieniasz and
Cullen, 2000; Marianii et al., 2000, 2001; and this study).
Covalent attachment of myristate, a 14-carbon saturated
FIG. 2. Membrane floatation centrifugation with p17MA, p24CA, and Gag precursors. Postnuclear supernatants were prepared and subjected to
membrane floatation centrifugation. Aliquots of each fraction were subjected to denaturating by 15% SDS–PAGE followed by electroblotting onto a
PVDF membrane and developed with a mixture of anti-p17 MA and anti-p24 CA MAbs. Proteins were visualized by using the enhanced
chemiluminescence method, subsequent to development with peroxidase-conjugated protein G.
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fatty acid catalyzed by N-myristoyl transferase (NMT) to
the Gly residue at position 2 of MA, had been shown to
be essential for virus particle assembly and release
(Bryan and Ratner, 1990; Gottlinger et al., 1989). The
N-terminal myristoylation of HIV-1 Pr55gag in murine cells
has not been directly analyzed. Thus, it remains possible
that species- or cell type-dependent differences in N-
terminal myristoylation and/or multimerization form the
basis for the apparent differences in Gag targeting/pro-
cessing and virion morphogenesis in different cell types.
To determine whether the Pr55gag translated in human
and rodent cells is in the myristoylated form, cells ex-
pressing HIV-1 gag, pol genes were metabolically la-
beled with [9,10(n)-3H]myristic acid. When HeLa cells
expressing HIV-1 gag–pol genes were used, radiola-
beled proteins of 55 and 41 kDa molecular size, corre-
sponding to Gag precursor Pr55gag and intermediate pre-
cursor Pr41gag, respectively, were clearly detected (Fig.
4). Radiolabeled Pr55 and Pr41 were also unequivocally
identified in murine NIH3T3 cells. An additional band of
160 kDa was detected, but only in NIH3T3 cells. This
band could represent the gag–pol precursor (Pr160gag-pol)
that is synthesized as a result of ribosomal frameshifting,
a process shown to occur efficiently in rodent cells
(Moosmayer et al., 1991; Bieniasz and Cullen, 2000). In
accordance with the expression levels of intracellular
Gag polyproteins in human and murine cells, intensities
of radiolabeled Pr55 and Pr41 bands in NIH3T3 cells
were weaker than those found in HeLa cells. Taken
together, evidence suggest that the lack of or inefficient
membrane targeting activity of HIV-1 Gag observed in
murine cells is not due to insufficient myristoylation.
While myristoylation of HIV-1 Gag is essential for mem-
brane binding, it is apparently not sufficient to determine
membrane targeting specificity.
FIG. 3. Confocal microscopy analysis of intracellular Gag polyprotein. HeLa and NIH3T3 cells expressing HIV-1 gag and pol genes were transiently
transfected with pEYFP vectors (CLONTECH) encoding yellow–green fluorescent variants of the enhanced green fluorescent proteins (EYFPs)
targeted to the plasma membrane (pEYFP-Mem), trans medial Golgi (pEYFP-Golgi), or ER (pEYFP-ER). After fixation and permeabilization, cells were
stained with MAbs against p24 CA and rhodamine-labeled antimouse IgG and analyzed by a confocal laser microscope. Colocalization of Gag and
organelle-specific EFYP is indicated in yellow in the merged images (Merge).
FIG. 4. Gag protein myristoylation. Cells were metabolically labeled
with [9,10(n)-3H]myristic acid. Cells were lysed, immunoprecipitated
with an anti-p24 CA MAb, and separated by 10% SDS–PAGE subse-
quent to the visualization using autography.
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Production of infectious virions from murine cells is
enhanced by heterokaryons formation between
human or mink cells
Although rodent cells did release small amounts of
p24 CA, it remained unclear whether this could be as-
sembled in the form of infectious virions. To determine
the relative infectivity of viruses produced from murine
cells, pseudotyped HIV-puro viruses were prepared by
transient transfection of cells with HIV-1 Env and VSV-G
expression plasmids and assessed for their potential to
infect HOShCD4hCCR5, a human osteosarcoma cell line
that expresses hu-CD4 and hu-CCR5. Puromycin-resis-
tant colonies were quantitated 10 days after infection.
Highly infectious single-round virus was recovered from
human HeLa cells carrying HIV-1 gag, pol genes when
the virus was pseudotyped with envelopes from R5 HIV-1
or heterologous VSV (Table 1). As a control, no puromy-
cin-resistant colonies were observed when 5 ng of VLP
recovered from HeLa cells without Env was exposed to
HOShCD4hCCR5 cells (data not shown). Comparable
titers of infectious virus were recovered when the mink
Mv.1.Lu cell was used as the producer cell. In contrast, a
20- to 50-fold reduction in infectivity of HOShCD4hCCR5
cells was observed when the single-round infectious
virus was produced in murine NIH 3T3-hCycT1 cells.
Observations using reciprocal heterokaryons sug-
gested that the reduced potential of rodent cells to pro-
duce infectious HIV-1 particles is attributed to the lack or
functional disorder of a cellular cofactor(s) essential for
virus assembly (Bieniasz and Cullen, 2000; Mariani et al.,
2001). To examine this further, murine NIH 3T3-hCycT1
cells carrying HIV-1 gag, pol genes were fused by PEG
treatment with human HeLa as well as mink Mv.1.Lu
cells. As can be seen in Fig. 5, fusion of murine NIH
3T3-hCycT1 cell expressing HIV-1 gag, pol genes with
human HeLa or mink Mv.1.Lu cells, but not with murine
NIH 3T3 cells, resulted in a significant increase (approx-
imately 20- to 30-fold) in the level of p24 CA release into
culture supernatants. This further demonstrates that the
TABLE 1
Titers of HIV-1-puro Packaged in Human, Mink, and Murine Cells
Pseudotyped with Different Envelopes
Producing
cells Envelope
No. of Puror colonies on
HOShCD4hCCR5a
0.5 ngb 5 ng
HeLa HIV-1 SF162 Env 12 3c 63 15
VSV-G 33 13 306 74
Mv.1.Lu HIV-1 SF162 Env 8 4 42 13
VSV-G 26 14 280 62
NIH3T3 HIV-1 SF162 Env 0 ND
VSV-G 2 1 6 2
a HOS cells expressing both CD4 and CCR5.
b Input virus.
c Results are means  standard deviations for duplicate determina-
tions.
FIG. 5. Heterokaryons between murine cells stably expressing hu-cyclin T1 and HIV-1 gag, pol genes with human or mink cells. Murine 3T3-hCycT1
carrying HIV-1 gag–pol genes was cultured along with an equal number of human HeLa or mink Mv.1.Lu cells. Cocultivated cells were fused with PEG,
and subsequent p24 CA production was analyzed after 24 h together with the non-PEG-treated control.
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assembly-resistant phenotype seen in murine NIH 3T3
cells can be complemented by phenotypic mixing with
human as well as mink cells.
To verify that heterokaryons from murine and human or
mink cells were also able to support the production of
infectious virus, murine NIH 3T3-hCycT1 expressing
HIV-1 gag–pol genes were transiently transfected with
VSV-G vector and subsequently fused by PEG treatment
with HeLa or Mv.1.Lu cells. The potential for pseudotyped
viruses generated to infect hCD4hCCR5HOS cells was
then determined. A greater than sevenfold increase in
infectivity was observed for pseudotyped viruses pro-
duced from NIH 3T3 murine cells after heterokaryon
formation between human or mink cells (Table 2). These
findings clearly show that virions produced among mu-
rine cells can be rendered more infectious by phenotypic
mixing with human as well as mink cells. This comple-
mentation in infectivity was a constant phenomenon in a
large series of experiments. We conclude that murine
NIH 3T3 cells lack some factor(s) necessary for the HIV-1
Gag assembly. These cellular cofactors appear to play
crucial roles in mediating HIV-1 infectivity and are func-
tional in both mink and human cells.
DISCUSSION
We obtained evidence for the heterogeneity in the
potential of cells from small animal to support the late
phase of HIV-1 replication. Among cells from nonhuman
vertebrates, avian chicken embryonic fibroblasts (CEF),
quail QT6, and mink (Mustera vison) lung Mv.1.Lu cells
were found to support Gag assembly and release more
efficiently than seen in rodent cells. A significant in-
traspecies variation was observed among rodent cells.
Consistent with previous reports (Mariani et al., 2000;
Bieniasz and Cullen, 2001), the defects appear to be
most profound in murine cells and can be partially over-
come by fusion with permissive human cells (Tables 1
and 2), findings which suggest the requirement of a
species-specific cellular factor(s) critical for HIV-1 as-
sembly (Bieniasz and Cullen, 2001; Mariani et al., 2001).
However, this assembly cofactor does not appear to be
human cell specific since HIV-1 Gag assembles effi-
ciently in avian and mink cells (Fig. 1B), and fusion with
mink cells also overcomes the assembly-defective phe-
notype seen in murine cells (Fig. 5). Indeed, efficient
HIV-1 particle assembly and release has been reported
to occur even in insect cells (Gheysen et al., 1989).
The basis for the defect in infectious virus production
in murine cells appears to be multiple. Gag gene expres-
sion was reduced in rodent cells, even in the presence of
hu-cyclin T1 expression. Since Rev has been shown to
be functional in rodent cells (Malim et al., 1991), the lower
expression of Gag expression could be due to instability
of the unspliced transcripts that serve as mRNAs for the
translation of Gag and Gag–Pol polyproteins. Alterna-
tively, there is inefficient transcription even in the pres-
ence of heterologous hu-cyclin T1.
In addition to reduced Gag gene expression, defects
in Gag trafficking were also observed in murine cells.
The myristoylation and basic motif in the N-terminal
region of Pr55gag are predicted to contribute to mem-
brane interactions via hydrophobic and electrostatic in-
teractions, respectively. Gag defective in myristoylation
was shown to form large cytosolic complexes (Hermida-
Matsumoto and Resh, 2000). In addition, acquisition of a
myristoylated and/or palmitoylated sequence from mu-
rine leukemia virus matrix or human Src family kinase
Fyn protein was reported to increase the assembly of
HIV-1 Gag in murine and human cells (Chen et al., 2001;
Lindwasser and Resh, 2001; Reed et al., 2002). Data from
our radiolabeling studies, however, show that Pr55gag
synthesized in human and murine cells is myristylated to
a comparable degree, indicating that the murine form of
NMT is functional with regard to transfer of myristate
from myristoyl-CoA to Pr55gag. Nevertheless, this myris-
toylated Pr55gag in murine cells does not appear to traffic
appropriately. Membrane floatation analyses indicate
that HIV-1 Gag is not efficiently targeted to cell mem-
branes in rodent species. Confocal microscopy reveals
that whereas Gag is membrane associated in human
cells, a diffused cytoplasmic presence is detected in
murine cells.
Localization of Gag polyprotein predominantly in a
cholesterol-rich region of the plasma membrane, known
as lipid rafts, has recently been reported, and a model for
assembly of both the HIV-1 Gag and Env in this mem-
brane microdomain is emerging (Nguyen and Hildreth,
2000; Rousso et al., 2000; Lindwasser and Resh, 2001;
Ono and Freed, 2001). Since removal of Gag multimer-
ization domains has shown to increase, rather than de-
crease, recovery of Gag proteins from lipid rafts (Lind-
wasser and Resh, 2001), the assembly defect is unlikely
to be due to the inability of the myristoylated HIV-1 Gag
polyproteins to multimerize in murine cells. Thus, it is
TABLE 2
Titer of HIV-1-puro Packaged in Murine 3T3 Cells Pseudotyped
with VSV-G after Heterokaryon Formation between Human or Mink
Cells
Fusion partner
No. of Puror colonies on
HOShCD4hCCR5a
0.5 ngb 5 ng
HeLa 16 3c 43 15
Mv.1.Lu 20 6 52 12
NIH 3T3 2 1 7 2
a HOS cells expressing both CD4 and CCR5.
b Input virus.
c Results are means  standard deviations for duplicate determina-
tions.
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tempting to speculate that the basis for the defect in
assembly and release of infectious HIV virions of rodent
cells is inefficient targeting of Gag polyproteins to the
plasma membrane. The function of a cellular cofactor(s)
that facilitates HIV assembly therefore could be to target
viral proteins specifically to the plasma membrane.
Gag polyprotein was also found to localize in the trans
cisternae of the Golgi regions (Fig. 3). This result ap-
pears to be at odds with data showing that only Gag with
mutations in the N-terminal basic residue cluster local-
izes to a region partly overlapping the trans medial re-
gion of the Golgi apparatus (Lindwasser et al., 2001). The
reason for this discrepancy is not clear but may be
related to the use of different probes to monitor this
organelle. When anticaveolin-1 MAb and rhodamine-la-
beled secondary antibody were used, overlay with EYFP-
Mem, but not with EYFP-Golgi, was observed (data not
shown). Caveolins are present in caveolae, flask-shaped
invaginations of the plasma membrane where there is a
subset of lipid rafts (Schnitzer et al., 1995). These results
may mean that HIV-1 Gag in human cells localized partly
at or near the Golgi and TGN-proximal region as well as
in plasma membrane.
The mink Mv.1.Lu cell line appears to support the
postintegration steps of HIV-1 replication with few, if any,
deficiencies compared to findings in human cell lines.
The block of HIV-1 infection in mink cells has been
shown to occur prior to proviral integration. Transfection
of full-length HIV-1 DNA into mink cells results in pro-
ductive infection (Levy et al., 1986), and HIV-1 replication
in mink cells has also been demonstrated using pheno-
typic mixing with amphotropic murine leukemia virus
(Canivet et al., 1990) or polyethylene glycol treatment
following HIV-1 adsorption (Clapham et al., 1991). Our
data complement and extend these earlier studies of
HIV-1 infection in this cell species. Species-specific
blocks in the function HIV-1 Tat and Rev function are
absent in mink cells. In fact, gene expression was com-
parable to that found in human cells in the absence of
exogenous hu-cyclin T1 expression. HIV-1 Gag polypro-
teins synthesized traffick to the plasma membrane as
efficiently as in human cells. Furthermore, HIV-1 replica-
tion in Mv.1.Lu cells expressing huCD4 and huCCR5 in
vitro approaches the level seen in human hCD4hCCR5HOS
cells (Koito et al., unpublished data); thus the mink
serves as a useful small animal model for HIV-1 infection
and disease.
In conclusion, there is an assembly block in rodent
cells, especially in murine cells. Among various vertebral
species, cell lines derived from avian and mink support
assemble and release of HIV-1 virions. These results
imply that a key assembly cofactor(s) is functional not
only in human cells but also in many other vertebrae, but
is absent in some rodent species. Additional studies are
required to characterize this block(s) through identifica-
tion of a species-specific cellular factor(s) that interacts
with HIV-1 Gag during viral assembly for the develop-
ment of murine models. Identification of such a human
factor(s) may lead to elucidation of new targets for ther-
apeutic intervention in HIV-1 infection and disease.
MATERIALS AND METHODS
Plasmids and reagents
The hu-cyclin T1 gene was amplified from pRC12/
CMV/huCycT1 (Bieniasz et al., 1998; provided by B. R.
Cullen, Duke University, Durham, NC) and inserted into
pBluescript (SKII) and the retroviral vector pLXSN
(Miller and Rosman, 1989, purchased from Clonetech,
Palo Alto, CA) to yield pSKII/hCycT1 and pLXSN/hCycT1,
respectively. In this recombinant retroviral vector, the
viral genomic mRNA is produced by LTR derived from
murine Moloney leukemia virus (MoMuLV) and the bac-
terial gene encoding resistance to G418 is initiated at an
internal SV40 promoter. Vesicular stomatatis virus G
(VSV-G)-expressing plasmids (pVSV-G) were obtained
from Clonetech. SV40-based HIV-1 Env expressing vec-
tor pSM-SF162-env has been described elsewhere (Koito
et al., 1994). pHIV-puro, which encodes full-length HIV-
1NL43 proviral DNA with a frameshift in the env gene, and
the SV40 promoter regulating puromycin-resistant gene,
was provided by R. Sutton (Stanford University Medical
Center, Stanford, CA). Plasmid pEYFP vectors encode
yellow-green fluorescent variants with four amino acid
substitutions of the A. victoria GFP that is optimized for
brighter fluorescence and higher expression in mamma-
lian cells (Ormo et al., 1996). pEYFP vectors fused with
the N-terminal plasma membrane targetting signal of
neuromodulin (pEYFP-Mem), the N-terminal 81 amino
acids of the precursor to the human -1,4-galactosyl-
transferase (pEYFP-Golgi) or endoplasmic reticulum (ER)
targeting sequence of calreticulin, and the ER retention
sequence, KDEL (pEYFP-ER) were from Clontech. All
plasmids were purified from transformed Escherichia
coli strain DH5 using the CONCERT High Purity Plas-
mid Maxiprep System (GIBCO BRL, Grand Island, NY).
Anti-p24CA (clone VAK4; IgG2b) monoclonal antibody
(MAb) was as described elsewhere (Koito et al., 1988).
Anti-p17MA (LG20-13-15) MAb was obtained from the
Chemo-Sero-Therapeutic Research Institute (Kikuchi, Ku-
mamoto, Japan). Anticaveolin-1 polyclonal antibody was
from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-
mouse fluorescein isothiocyanate (FITC), antimouse rho-
damine, and antirabbit rhodamine secondary antibodies
were purchased from DAKO (Glostrup, Denmark).
Cells
The human T lymphoid cell line PM1, murine T lym-
phoma cell line EL4, BW5147, macrophage line RAW264,
and WKA rat-derived myelomonocytic precursor cell line
WRT7 (provided by M. Hosokawa; Hokkaido University,
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Sapporo, Japan) were propagated in RPMI 1640 medium
(GIBCO BRL). Human HeLa, 293T, the MoMuLV retroviral
packaging cell line GP293 (CLONTECH), quail QT6, mink
(M. vision) lung Mv.1.Lu (ATCC CCL-64), mouse muscle
cell NOR10 (ATCC CCL-198), and fibroblast cell NIH3T3
were maintained in Dulbecco’s modified Eagle’s medium
(GIBCO BRL). Chinese hamster ovary (CHO) K1 (ATCC
CCL-61) cells were cultured in F-12 medium (Life Tech-
nologies, Rockville, MD). Chicken embryo fibroblasts
(CEFs) were prepared and cultured as described (Shige-
kane et al., 1999; provided by M. Sakaguchi; Kikuchi
Research Center, Chemo-Sero-Therapeutic Research In-
stitute). Human HOS cells stably expressing both the
hu-CD4 molecule containing a cytoplasmic tail deletion
and hu-CCR5 have been reported (Tahara-Hanaoka et
al., 2000). All media were supplemented with 10% heat-
inactivated (56°C for 30 min) fetal bovine serum (GIBCO
BRL) and cells were cultured at 37°C and 5% CO2 in a
humidified chamber.
Nonhuman animal cell lines expressing hu-cyclin T1
were generated by transducing cells with hu-cyclin T1
retroviral expression vector pLXRN/hCycT pseudotyped
with VSV-G followed by 4 weeks of selection in the
presence of 0.5 mg/ml of G418 (Geneticin; GIBCO BRL).
This hu-cyclin-T1-expressing retrovirus was generated
by cotransfecting GP293 cells with pLXSN/hCycT and
pVSV-G. Replication-incompetent HIV-puro pseudotypes
were generated by cotransfecting 293T cells with pHIV-
puro and pVSV-G. Transfections were done using Lipo-
fectamine 2000 (Life Technologies, Gaithersburg, MD)
according to the manufacturer’s instructions. Culture su-
pernatants were harvested at 2 days posttransfection
and stored at 70°C.
FACS analysis
Staining for intracytoplasmic HIV-1 p24 was done us-
ing the Fix and Perm reagents (Caltag Laboratories,
Burlingame, CA), as described (Atchison et al., 1996),
using a MAb to p24 CA (VAK4) and FITC-conjugated goat
antimouse IgG. The cells were then washed with Ca2-,
Mg2-free phosphate-buffered saline PBS() and resus-
pended in staining medium (PBS(), 0.05% NaN3, and 3%
FCS) containing propidium iodide (PI) (1 g/ml). Amounts
of intracellular p24 CA were then measured using a
FACSCalibur (Beckton–Dickinson, San Jose, CA) by ana-
lyzing fluorescence using the Cell Quest software (Beck-
ton–Dickinson).
Cell fractionation and sucrose floatation assays
The flotation assay was done as described (Spearman
et al., 1997) but with minor modifications. Cells (2  107)
were harvested, rinsed twice with ice-cold PBS(), re-
suspended in 300 l of ice-cold hypotonic TE (10 mM
Tris–HCl, pH 7.5, and 1 mM EDTA) buffer containing 10%
(wt/vol) sucrose and a protease inhibitor cocktail (Roche;
Mannheim, Germany) and then allowed to swell on ice
for 15 min. These cells, then disrupted on ice by sonica-
tion (15 s, twice); nuclei and cell debris were pelleted by
centrifugation (1000 g for 10 min at 4°C) and the resulting
postnuclear extracts (250 l) were then mixed with 1.25
ml of 85.5% (wt/vol) sucrose in TE buffer, adjusted to 80%
(wt/vol) sucrose, placed at the bottom of a SW41 centri-
fuge tube, and overlaid with 65% (wt/vol) and 10% (wt/vol)
sucrose in TE buffer. Standard volumes for this step
gradient included 1.5 ml of 80% and 6 ml of 65% sucrose
and the remaining portion of the centrifugation tube was
filled with 10% sucrose in TE buffer. For centrifugation,
we used a Beckman SW41 TI rotor at 30,000 rpm for 18 h
at 4°C. Ten 1.0-ml fractions were collected from the top of
the gradient. Aliquots of each fraction were separated by
15% polyacrylamide gel electrophophoresis containing
sodium dodecyl sulfate (SDS–PAGE; Bio-Rad, Hercules,
CA), transferred to polyvinylidine difluoride (PVDF) filters
(Bio-Rad), and probed with a mixture of antibodies to p24
CA VAK4 and p17 MA LG20-13-15 followed by horserad-
ish peroxidase-coupled protein G (Bio-Rad). Filters were
developed using enhanced chemiluminescence re-
agents (ECL; Amersham, Buckinghamshire, England).
Immunofluorescence microscopy and confocal
analysis
Cells transiently transfected with pEYFP-Mem, pEYFP-
Golgi, or pEYFP-ER using Lipofectamine 2000 were re-
seeded into 35-mm poly-L-lysine-coated dish coverslips
(Matsunami Glass Co., Osaka, Japan) and grown for 24 h
at 37°C in DMEM containing 10% FCS, then fixed with
3.7% formaldehyde in PBS() for 15 min, permeabilized
with 0.05% saponin and 0.2% bovine serum albumin
(BSA) in PBS for 10 min at room temperature, and sub-
sequently washed twice in PBS. For antibody staining,
coverslips were incubated in a humid chamber at 37°C
for 1 h with a MAb to p24 CA VAK4 for 1 h and with a
rhodamine-conjugated rabbit antimouse IgG for 30 min
at the appropriate dilution in 1% BSA and 0.02% Na azide
in PBS(). After three washings with PBS(), these cells
were mounted with FLUORESCENT MOUNTING ME-
DIUM (DAKO). For confocal microscopy, images were
acquired with a Plan-Neofluar 100 oil immersion ob-
jective (Zeiss, Tokyo, Japan) and a Zeiss LSM 510 in-
verted laser scanning microscope. Beams (488 nm for
FITC, 543 nm for He–Ne) from an argon and He–Ne laser
were used. For two-color analysis, green and red emis-
sions were simultaneously recorded through appropriate
filters (505- to 530-nm bandpass filter for FITC and
585-nm long-pass filter for rhodamine) and stored in
separate (red and green) image channels. Image quality
was enhanced during data acquisition using the LSM
line average feature. Postacquisition digital image en-
hancement was done using the LSM software.
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N-Myristoylation
[9,10(n)-3H]Myristic acid (catalog No. TRK907; Amer-
sham), which was supplied in ethanol, was first vacuum
dried and dissolved in dimethyl sulfoxide. Cells were
metabolically labeled overnight with [9,10(n)-3H]myristic
acid (0.5 mCi/ml) in DMEM medium supplemented with
10% FCS. The cells were washed twice with PBS() and
lysed in the radioimmunoprecipitation (RIPA; 0.15 M
NaCl, 0.05 M Tris–HCl, pH 7.2, 1% Triton X-100, 1% so-
dium deoxycholate, and 0.1% sodium dodecyl sulfate)
buffer containing a protease inhibitor cocktail (Roche).
Proteins were immunoprecipitated with anti-p24 CA MAb
VAK4 followed by immobilization on protein G–Sepha-
rose (Amersham Pharmacia Biotech AB, Uppsala, Swe-
den). The immunoprecipitate was washed three times
with RIPA buffer and solubilized in Laemmli’s sample
buffer. The radiolabeled proteins were size-fractionated
by 10% SDS–PAGE, followed by autoradiography.
Pseudotyped virus production and transduction
HeLa, mink Mv.1.Lu, or murine NIH 3T3 carrying hu-
cyclin T1 (3T3-hCycT1) cells expressing HIV-1 gag, pol
genes (5  106 per 10-cm dish) were transfected using
Lipofectamine 2000 with 10 g of the pSM-SF162-env
vector together with 5 g of rev-expressing vector. Alter-
natively, replication-incompetent viruses were generated
by transfection of 10 g of VSV-G vector. The
pseudotyped virus-containing culture supernatants of
transfected cells were harvested at 48 h posttransfec-
tion. Supernatants were cleared of cellular debris by
centrifugation at 500 g for 5 min and stored at 70°C,
subsequent to a filtration through a 0.45-m pore size
filter and analyzed for HIV-1 p24 content by an enzyme-
linked immunosorbent assay kit (ZeptoMetrix Corporation,
Buffalo, NY). Virus pseudotyped by VSV-G was concen-
trated (141,000 g for 4 h at 4°C) and resuspended in a
small amount of DMEM medium. A total of 106 target
human osteosarcoma cells expressing both CD4 and
CCR5 (HOShCD4hCCR5; Tahara-Hanaoka et al., 2000)
were plated on a 35-mm-diameter six-well culture plate
and incubated with transfected cell media and 6 g/ml of
polybrene (Sigma Chemical Co., St. Louis, MO) for 3 h at
37°C, at which time 4 ml of complete medium was added
and the incubation was continued. The medium was
replaced 2 days later with medium containing 5 g/ml of
active puromycin for 10 days. The selection medium was
changed every 2 to 3 days, and visible colonies arose
typically in 6 to 9 days. These colonies were then stained
with crystal violet.
Heterokaryon formation
Murine 3T3-hCycT1 cells (5  105) stably expressing
HIV-1 gag–pol gene products were cocultured with an
equal number of human HeLa, mink Mv.1.Lu, or murine
NIH 3T3 cells in a culture plate (35-mm-diameter). After
12 h, medium was aspirated and the cells were washed
once with serum-free medium. Then the cells were fused
by adding 1.0 ml of a prewarmed 50% (wt/vol) polyethyl-
ene glycol [PEG (HYBRI-MAX; Sigma)] solution in DMEM
for 2 min at 37°C. PEG was extensively washed, and
heterokaryons were cultured for another 24 h. Culture
supernatants was collected and the p24 CA content was
monitored.
ACKNOWLEDGMENTS
We thank C. Cheng-Mayer for critical review of the manuscript and
B. R. Cullen, R. Sutton, M. Hosokawa, and M. Sakaguchi for donating
materials. We also thank K. Nishihara, T. Kimura, and T. Shimasaki for
technical assistance; W. Song for assistance with confocal fluores-
cence microscopy; S. Shoji, K. Yoshimura, and Y. Kameyama for dis-
cussions; and M. Tsukiashi for secretarial services. This work was
supported in part by a grant-in-aid for Scientific Research from the
Ministry of Education of Japan.
REFERENCES
Atchison, R. E., Gosling, J., Monteclaro, F. S., Franci, C., Digilio, L.,
Charo, I. F., and Goldsmith, M. A. (1996). Multiple extracellular ele-
ments of CCR5 and HIV-1 entry: Dissociation from response to
chemokines. Science 274, 1924–1926.
Bieniasz, P. D., Grdina, T. A., Bogerd, H. P., and Cullen, B. R. (1998).
Recruitment of a protein complex containing Tat and cyclin T1 to TAR
governs the species specificity of HIV-1 Tat. EMBO J. 17, 7056–7065.
Bieniasz, P. D., and Cullen, B. R. (2000). Multiple blocks to human
immunodeficiency virus type 1 replication in rodent cells. J. Virol. 74,
9868–9877.
Browning, J., Horner, J. W., Pettoello-Mantovani, M., Raker, C., Yurasov,
S., DePinho, R. A., and Goldstein, H. (1997). Mice transgenic for
human CD4 and CCR5 are susceptible to HIV infection. Proc. Natl.
Acad. Sci. UCA 94, 14637–14641.
Bryant, M., and Ratner, L. (1990). Myristoylation-dependent replication
and assembly of human immunodeficiency virus 1. Proc. Natl. Acad.
Sci. USA 87, 523–527.
Canivet, M., Hoffman, A. D., Hardy, D., Sernatinger, J., and Levy, J. A.
(1990). Replication of HIV-1 in a wide variety of animal cells following
phenotypic mixing with murine retroviruses. Virology 178, 543–551.
Chen, B. K., Rousso, I., Shim, S., and Kim, P. S. (2001). Efficient assembly
of an HIV-1/MLV Gag-chimeric virus in murine cells. Proc. Natl. Acad.
Sci. USA 98, 15239–15244.
Clapham, P. R., Blanc, D., and Weiss, R. A. (1991). Specific cell surface
requirements for the infection of CD4-positive cells by human immu-
nodeficiency virus types 1 and 2 and by simian immunodeficiency
virus. Virology 181, 703–715.
Freed, E. O. (1998). HIV-1 gag proteins: Diverse functions in the virus life
cycle. Virology 251, 1–15.
Freed, E. O., Orenstein, J. M., Buckler-White, A. J., and Martin, M. A.
(1994). Single amino acid changes in the human immunodeficiency
virus type 1 matrix protein block virus particle production. J. Virol. 68,
5311–5320.
Garber, M., Wei, P., KewalRamani, V., Mayall, T., Herrmann, C., Rice, A.,
Littman, D., and Jones, K. (1998). The interaction between HIV-1 Tat
and human cyclin T1 requires zinc and a critical cysteine residue that
is not conserved in the murine CycT1 protein. Genes Dev. 12, 3512–
3527.
Gheysen, D., Jacobs, E., de Foresta, F., Thiriart, C., Francotte, M.,
Thines, D., and De Wilde, D. (1989). Assembly and release of HIV-1
precursor Pr55gag virus-like particles from recombinant baculovirus-
infected insect cells. Cell 59, 103–112.
190 KOITO, SHIGEKANE, AND MATSUSHITA
Gottlinger, H. G., Sodrosky, J. G., and Haseltine, W. A. (1989). Role of
capsid precursor processing and myristoylation in morphogenesis
and infectivity of human immunodeficiency virus. Proc. Natl. Acad.
Sci. USA 86, 5781–5785.
Hermida-Matsumoto, L., and Resh, M. D. (2000). Localization of human
immunodeficiency virus type 1 Gag and Env at the plasma mem-
brane by confocal imaging. J. Virol. 74, 8670–8679.
Keppler, O. T., Welte, F. J., Ngo, T. A., Chin, P. S., Patton, K. S., Tsou, C.-L.,
Abbey, N. W., Sharkey, M. E., Grant, R. M., You, Y., Scarborough, J. D.,
Ellmeier, W., Littman, D. R., Stevenson, M., Charo, I. F., Herndier, B. G.,
Speck, R. F., and Goldsmith, M. A. (2002). Progress toward a human
CD4/CCR5 transgenic rat model for de novo infection by human
immunodeficiency virus type 1. J. Exp. Med. 195, 719–736.
Koito, A., Harrowe, G., Levy, J. A., and Cheng-Mayer, C. (1994). Func-
tional role of the V1/V2 region of human immunodeficiency virus type
1 envelope glycoprotein gp120 in infection of primary macrophages
and sCD4 neutralization. J. Virol. 68, 2253–2259.
Koito, A., Hattori, T., Matsushita, S., Maeda, Y., Nozaki, C., Sagawa, K.,
and Takatsuki, K. (1988). Conserved immunogenic region of a major
core protein (p24) of human and simian immunodeficiency viruses.
AIDS Res. Hum. Retroviruses 4, 409–417.
Kwak, Y. T., Ivanov, D., Guo, J., Nee, E., and Gaynor, R. B. (1999). Role of
the human and murine cyclin T proteins in regulating HIV-1 tat-
activation. J. Mol. Biol. 288, 57–69.
Leonard, J. M., Abramczuk, J. W., Pezen, D. S., Rutledge, R., Belcher,
J. H., Hakim, F., Shearer, G., Lamperth, L., Travis, W., Fredrickson, T.,
Notkins, A. L., and Martin, M. A. (1988). Development of disease and
virus recovery in transgenic mice containing HIV proviral DNA. Sci-
ence 242, 1665–1670.
Levy, J. A., Cheng-Mayer, C., Dina, D., and Luciw, P. A. (1986). AIDS
retrovirus (ARV-2) clone replicates in transfected human and animal
fibroblasts. Science 232, 998–1001.
Lindwasser, O. W., and Resh, M. D. (2001). Multimerization of human
immunodeficiency virus type 1 Gag promotes its localization to
barges, raft-like membrane microdomains. J. Virol. 75, 7913–7924.
Llopis, J., McCaffery, J. M., Miyawaki, A., Farquhar, M. G., and Tsien, R. Y.
(1998). Measurement of cytosolic, mitochondrial, and Golgi pH in
single living cells with green fluorescent proteins. Proc. Natl. Acad.
Sci. USA 95, 6803–6808.
Malim, M. H., McCarn, D. F., Tiley, L. S., and Cullen, B. R. (1991).
Mutational definition of the human immunodeficiency virus type 1
Rev activation domain. J. Virol. 65, 4248–4254.
Mariani, R., Rutter, G., Harris, M. E., Hope, T. J., Krausslich, H.-G., and
Landau, N. R. (2000). A block to human immunodeficiency virus type
1 assembly in murine cells. J. Virol. 74, 3859–3870.
Mariani, R., Rasala, B. A., Rutter, G., Wiegers, K., Brandt, S. M., Kraus-
slich, H.-G., and Landau, N. R. (2001). Mouse-human heterokaryons
support efficient human immunodeficiency virus type 1 assembly.
J. Virol. 75, 3141–3151.
Miller, A. D., and Rosman, G. J. (1989). Improved retroviral vectors for
gene transfer and expression. BioTechniques 7, 980–990.
Moosmayer, D., Reil, H., Ausmeier, M., Scharf, J.-G., Hauser, H., Jentsch,
K. D., and Hunsmann, G. (1991). Expression and frameshifting but
extremely inefficient proteolytic processing of the HIV-1 gag and pol
gene products in stably transfected rodent cell lines. Virology 183,
215–224.
Nguyen, D. H., and Hildreth, J. E. (2000). Evidence for budding of human
immunodeficiency virus type 1 selectively from glycolipid-enriched
membrane lipid rafts. J. Virol. 74, 3264–3272.
Ono, A., and Freed, E. O. (2001). Plasma membrane rafts play a critical
role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. USA 98,
13925–13930.
Ormo, M., Cubitt, A. B., Kallio, K., Gross, L. A., Tsien, R. Y., and Rem-
ington, S. J. (1996). Crystal structure of the Aequorea victoria green
fluorescent protein. Science 273, 1392–1395.
Reed, M., Mariani, R., Sheppard, L., Pekrun, K., Landau, N. R., and
Soong, N.-W. (2002). Chimeric human immunodeficiency virus type 1
containing murine leukemia virus matrix assembles in murine cells.
J. Virol. 76, 436–443.
Rousso, I., Mixon, M. B., Chen, B. K., and Kim, P. S. (2000). Palmitoylation
of the HIV-1 envelope glycoprotein is critical for viral infectivity. Proc.
Natl. Acad. Sci. USA 97, 13523–13525.
Sawada, S., Gowrishankar, K., Kitamura, R., Suzuki, M., Suzuki, G.,
Tahara, S., and Koito, A. (1998). Disturbed CD4 T cell homeostasis
and in vitro susceptibility in transgenic mice expressing T cell line-
tropic HIV-1 receptors. J. Exp. Med. 187, 1439–1449.
Schnitzer, J. E., McIntosh, D. P., Dvorak, A. M., Liu, J., and Oh, P. (1995).
Separation of caveolae from associated microdomains of GPI-an-
chored proteins. Science 269, 1435–1439.
Shigekane, H., Kawaguchi, Y., Shirakata, M., Sakaguchi, M., and Hirai,
K. (1999). The bi-directional transcriptional promoters for the latency-
relating transcripts of the pp38/pp24 mRNAs and the 1.8 kb-mRNA in
the long inverted repeats of Marek’s disease virus serotype 1 DNA
are regulated by common promoter-specific enhancers. Arch. Virol.
144, 1893–1907.
Spearman, P., Horton, R., Ratner, L., and Kuli-Zade, I. (1997). Membrane
binding of human immunodeficiency virus type 1 matrix protein in
vivo supports a conformational myristyl switch mechanism. J. Virol.
71, 6582–6592.
Tahara-Hanaoka, S., Ushijima, Y., Tarui, H., Wada, M., Hara, T., Imanishi,
S., Yamaguchi, T., Hattori, T., Nakauchi, H., and Koito, A. (2000).
Differential level in co-down-modulation of CD4 and CXCR4 primed
by HIV-1 gp120 in response to phorbol ester, PMA, among HIV-1
isolates. Microbiol. Immunol. 44, 489–498.
Wei, P., Garber, M. E., Fang, S. M., Fischer, W. H., and Jones, K. (1998).
A novel CDK9-associated C-type cyclin interacts directly with HIV-1
Tat and mediates its high-affinity, loop-specific binding to TAR RNA.
Cell 92, 451–462.
191HIV-1 GAG ASSEMBLY IN CELLS FROM SMALL ANIMALS
